rituximab,azathioprine
roche,biogen
['ritux', 'imab ']
prof. presents pooled/long term analysis of the mainritsan trials in aav. &gt; fixed maintenance with rituximab /6month is better to prevent relapse compared to individually tailored rtx infusion and to azathioprine treatment. #acr22
&gt;ms 
Annals of the Rheumatic Diseases (#1 research journal in Rheumatology) & RMD Open are the official @EULAR_ORG journals. High quality, peer reviewed research.